| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Internal Medicine (I.T., A.W., E.D., P.E., K.D., J.H., K.H., W.S., J.R.P., A.R.), Innsbruck Medical University, A-6020 Innsbruck, Austria; Institut Pasteur de Lille (C.F.), Département dAthérosclérose, and Institut National de la Santé et de la Recherche Médicale (C.F.), Unité 545, Lille F-59019, France; Université de Lille 2 (C.F.), Faculté des Sciences Pharmaceutiques et Biologiques et Faculté de Médecine, Lille F-59006, France; Laboratory of Pediatrics (F.S.), Center for Liver, Digestive and Metabolic Diseases, University Medical Center Groningen, 9700 Groningen, The Netherlands; and Karolinska Institute at Center for Endocrinology, Metabolism and Diabetes (M.R.), Department of Medicine, Karolinska University Hospital, and Molecular Nutrition Unit, Center for Nutrition and Toxicology, SE-171 77 Stockholm, Sweden
Address all correspondence and requests for reprints to: Ivan Tancevski, Department of Internal Medicine, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria. E-mail: ivan.tancevski{at}i-med.ac.at.
The aim of the study was to investigate the influence of severe hyperthyroidism on plasma high-density lipoprotein cholesterol (HDL-C). Recently, it was shown in mice that increasing doses of T3 up-regulate hepatic expression of scavenger receptor class B, type I, resulting in increased clearance of plasma HDL-C. Here, we show that severe hyperthyroidism in mice did not affect hepatic expression of scavenger receptor class B, type I, but reduced hepatic expression of ATP-binding cassette transporter 1, accompanied by a 40% reduction of HDL-C. The sterol content of bile, liver, and feces was markedly increased, accompanied by up-regulation of hepatic cholesterol 7
-hydroxylase, and ATP-binding cassette transporter 5, which is known to promote biliary sterol secretion upon dimerization with ATP-binding cassette transporter 8. Both control and hyperthyroid mice exerted identical plasma clearance of iv injected [3H]HDL-C, supporting the view that severe hyperthyroidism does not affect HDL-C clearance but, rather, its formation via hepatic ATP-binding cassette transporter 1.
This article has been cited by other articles:
![]() |
I. Tancevski, A. Wehinger, E. Demetz, J. Hoefer, P. Eller, E. Huber, U. Stanzl, K. Duwensee, K. Auer, W. Schgoer, et al. The thyromimetic T-0681 protects from atherosclerosis J. Lipid Res., May 1, 2009; 50(5): 938 - 944. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |